Predictions
Invitae Corp
Start price
Target price
Perf. (%)
€3.50
21.08.22
21.08.22
€1.00
21.08.23
21.08.23
-21.28%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Invitae Corp
Start price
Target price
Perf. (%)
€3.32
26.08.22
26.08.22
-
26.08.23
26.08.23
-17.03%
03.09.22
03.09.22
Could be very worthwhile Investment >20% year
Molina Healthcare
Start price
Target price
Perf. (%)
€247.40
20.10.21
20.10.21
€280.00
31.12.23
31.12.23
39.05%
01.09.22
01.09.22
Could be very worthwhile Investment >20% year
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€91.50
10.08.21
10.08.21
-
10.08.22
10.08.22
-42.25%
10.08.22
10.08.22
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€33.09
30.10.21
30.10.21
€45.00
31.12.23
31.12.23
94.65%
05.08.22
05.08.22
Could be very worthwhile Investment >20% year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€152.65
16.11.21
16.11.21
€200.00
31.01.25
31.01.25
36.59%
03.08.22
03.08.22
Could be worthwhile Investment >10% per year
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€38.17
08.07.21
08.07.21
-
08.07.22
08.07.22
30.25%
08.07.22
08.07.22
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€9.23
09.11.21
09.11.21
€7.00
31.12.23
31.12.23
-56.18%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Invitae Corp
Start price
Target price
Perf. (%)
€25.10
09.06.21
09.06.21
€30.00
09.06.22
09.06.22
-89.88%
10.06.22
10.06.22
Could be worthwhile Investment >10% per year
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€2.81
30.05.22
30.05.22
-
30.05.23
30.05.23
23.85%
08.06.22
08.06.22
Risky Investment
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€54.60
08.07.21
08.07.21
-
08.07.22
08.07.22
-37.34%
21.05.22
21.05.22
Ensign Group Inc.
Start price
Target price
Perf. (%)
€71.50
03.05.21
03.05.21
€78.00
03.05.22
03.05.22
2.80%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.77
28.04.22
28.04.22
€25.00
28.04.23
28.04.23
19.70%
03.05.22
03.05.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Nektar Therapeutics
Start price
Target price
Perf. (%)
€4.42
19.04.22
19.04.22
-
19.04.23
19.04.23
-2.94%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€132.55
08.07.21
08.07.21
€150.00
08.07.22
08.07.22
-76.58%
29.04.22
29.04.22
Future proof or reliable business model
Top 10 in its market
Innovative
Growths faster than the competition
Teladoc Health Inc
Start price
Target price
Perf. (%)
€54.20
16.03.22
16.03.22
€65.00
16.03.23
16.03.23
-43.24%
28.04.22
28.04.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Teladoc Health Inc
Start price
Target price
Perf. (%)
€158.00
04.04.21
04.04.21
€75.00
04.04.22
04.04.22
-56.02%
05.04.22
05.04.22
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
ROE higher than 10% per year
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.74
20.02.22
20.02.22
€30.00
20.03.22
20.03.22
2.76%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Novocure Ltd
Start price
Target price
Perf. (%)
€59.26
09.01.22
09.01.22
€51.00
09.01.23
09.01.23
8.34%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group